Sharechat Logo

Strategic has loss of $15.5m on bad debts

Wednesday 20th August 2008

Text too small?
Strategic Finance, whose managers are seeking to buy the ailing company, had a full-year operating loss of about NZ$15.5 million on write-offs and provisions for bad debts.

The final amount of the loss for the year ended June 30 will be known once KPMG completes an audit, Strategic said in a statement. Its full results will be posted on August 29.

Strategic's loan book is being reviewed by adviser KordaMentha and KPMG, the company's auditor, to enable it to complete its financial statements and "in view of the increasingly difficult market conditions in the property sector."

"This is a disappointing result but it is considered appropriate in the current economic environment to adopt a conservative view" of the loan book, chief executive Kerry Finnigan said. "There are likely to be further loan defaults."

Under a plan to restructure the company, Strategic would repay 30% of its debentures over three years and issue new bonds to replace the rest to save the company.

The capital restructuring is dependent on Strategic's managers, directors and partner BOS International clinching a buyout deal for the business from owner Allco HIT, it said this month.

By extending the period for repayments and amending the interest paid, Strategic may buy enough time to recover from a slump in liquidity that's hampered the company's ability to pay investors.

By Jonathan Underhill



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report